Typhoid Fever: The Step-by-Step Progression and Complications

Typhoid fever is a life-threatening systemic illness caused by Salmonella enterica serotype Typhi. Unlike common food poisoning salmonellosis, typhoid is not a gut-limited infection — the bacteria enter the bloodstream and seed organs throughout the body. Without treatment, it progresses through four recognizable weeks of escalating illness, with a real risk of intestinal perforation and death. Even with antibiotics, recovery takes weeks. Understanding the progression week by week helps patients and families know what to watch for, when to seek emergency care, and why this disease demands more than symptom management at home.

  1. Salmonella Typhi vs. Paratyphi
  2. Week 1: Insidious Onset and Rising Fever
  3. Week 2: Classic Typhoid Signs — Rose Spots and Bradycardia
  4. Week 3–4: Complications and Resolution
  5. Intestinal Perforation: A Surgical Emergency
  6. Chronic Carriage and the Typhoid Mary Phenomenon
  7. Travelers Acquiring Typhoid
  8. Differential Diagnosis: What Else Looks Like Typhoid?
  9. Key Research Papers
  10. Connections
  11. Featured Videos

Salmonella Typhi vs. Paratyphi: Two Pathogens, One Clinical Syndrome

When doctors say "typhoid fever," they usually mean infection with Salmonella enterica serotype Typhi — but there is a closely related illness called paratyphoid fever, caused by Salmonella enterica serotypes Paratyphi A, B, and C. Both diseases are grouped under the term "enteric fever," and they look almost identical in the early going. The distinction matters for epidemiology and for understanding severity.

Salmonella Typhi is the more dangerous pathogen. It causes classical typhoid fever — higher fevers, more severe systemic illness, a greater risk of complications like intestinal perforation, and higher mortality if untreated (historically 10–30% case fatality before antibiotics). Typhi has a polysaccharide capsule called the Vi antigen, which helps it evade the immune system and contributes to its ability to persist in the body. It is exquisitely adapted to human beings.

Salmonella Paratyphi A and B cause a clinically milder disease, though still serious. The fever course tends to be shorter (1–2 weeks rather than 3–4), complications are less common, and mortality is substantially lower. Paratyphi C is rare. Importantly, the oral typhoid vaccine (Ty21a) and the polysaccharide Vi vaccine do not protect against paratyphoid — they target the Vi antigen found only on Typhi. The conjugate typhoid vaccine (Typbar-TCV, now WHO-recommended) also targets only Typhi.

Both serotypes share a critical epidemiological feature: humans are the only reservoir. There are no animal reservoirs for Typhi or Paratyphi. This is a fundamental difference from non-typhoidal Salmonella (like S. Typhimurium), which circulates freely in poultry, cattle, reptiles, and other animals. The human-only reservoir of Typhi means that transmission is always fecal-oral from another human — contaminated water, contaminated food handled by an infected person, or direct contact with a chronic carrier. This is why typhoid is tightly linked to sanitation infrastructure. Countries with reliable sewage treatment and clean water essentially eliminated typhoid without mass vaccination. Countries without that infrastructure still carry the burden today.

Globally, an estimated 11–21 million typhoid cases occur each year, with approximately 128,000–161,000 deaths. The disease is concentrated in South Asia (India, Pakistan, Bangladesh, Nepal account for roughly 70% of global cases), sub-Saharan Africa, and Southeast Asia. In high-income countries, typhoid is almost exclusively an imported disease seen in returned travelers or recent immigrants.

Week 1: Insidious Onset and Rising Fever

One of the most clinically important features of typhoid fever is that it does not start suddenly. There is no dramatic onset — no single moment when a person feels fine and then crashes. Instead, typhoid creeps in over days, which is exactly why people often dismiss it as a bad flu or dismiss the need for medical care until the illness has progressed significantly.

The incubation period — from swallowing Typhi bacteria to first symptoms — is typically 6 to 30 days, with an average around 8–14 days depending on the infectious dose. After ingestion, the bacteria penetrate the small intestinal wall, reach the lymph nodes in the gut (Peyer's patches), and begin multiplying inside macrophages. This silent incubation ends when enough bacteria spill into the bloodstream — the bacteremia phase — triggering the immune response that produces the first symptoms.

The Wunderlich curve — named for the 19th-century German physician who meticulously charted typhoid temperatures — describes the characteristic step-wise fever rise. Temperature climbs roughly 0.5–1°C per day during the first week, starting around 37.5–38°C and reaching 39–40°C by the end of week one. This staircase pattern on a temperature chart is a classic bedside clue. Modern thermometer use and early antibiotic treatment mean most patients never complete the full curve, but recognizing the step-wise pattern helps clinicians suspect typhoid before lab results return.

Early Week 1 symptoms typically include:

By the end of week one, bacteremia is established. The bacteria are circulating in the blood, seeding the liver, spleen, bone marrow, and gallbladder. Blood cultures drawn during this week have the highest yield — 80–90% sensitivity — because the bacterial load in the blood is at its peak before the immune response begins containing it.

The key clinical message for week one: this does not feel like ordinary food poisoning. Someone with typhoid in week one does not have acute vomiting and diarrhea. They have a gradually worsening fever, headache, and a sense that something is seriously wrong. Anyone returning from a typhoid-endemic region with this pattern needs blood cultures, not just rest and fluids.

Week 2: Classic Typhoid Signs — Rose Spots, Bradycardia, and Hepatosplenomegaly

If week one is the creep, week two is the declaration. By this point, the fever has reached its plateau — typically 39–40°C (102–104°F), sustained through most of the day with slight dips in the morning (remittent pattern). The systemic illness is now fully expressed, and three findings appear that, when seen together, are nearly pathognomonic for typhoid fever.

Rose Spots

Rose spots are the most iconic physical sign of typhoid. They appear in approximately 20–30% of patients with typhoid fever — meaning most patients with typhoid do not have them, but when they are present, they are very suggestive of the diagnosis.

Rose spots are small (2–4 mm), salmon-colored, slightly raised macules that blanch with pressure. They appear most commonly on the trunk — the abdomen and lower chest — typically in crops of 10–20 lesions. They are subtle and easy to miss, particularly in patients with darker skin tones. The spots last 3–5 days each and may appear in successive crops. They represent foci of bacteria in the skin's blood vessels surrounded by inflammatory cells.

Clinically, if you are examining a febrile patient returning from South Asia and you notice these faint salmon-colored spots on their abdomen while doing your exam, that is a significant diagnostic signal. Many clinicians never actively look for rose spots and miss them entirely.

Relative Bradycardia (Faget's Sign)

Under normal circumstances, every degree Celsius of fever raises the heart rate by approximately 10 beats per minute. A patient with a 40°C fever should have a heart rate around 100–110 bpm. In typhoid fever, this relationship breaks down. Many typhoid patients have a heart rate that is slower than expected for their fever level — a phenomenon called relative bradycardia, also known as Faget's sign (originally described in yellow fever, but equally applicable to typhoid).

A patient with a 40°C fever and a pulse of 70–80 bpm has relative bradycardia. This sign is present in roughly 30–50% of typhoid cases. It is thought to result from the direct effect of Salmonella endotoxin on cardiac conduction tissue. Its diagnostic value is greatest when combined with other features of typhoid.

Relative bradycardia also has differential diagnostic value: it is NOT typically seen in malaria, dengue, or bacterial pneumonia — illnesses that commonly mimic typhoid. When a febrile traveler has both rose spots AND relative bradycardia, typhoid moves sharply to the top of the differential diagnosis.

Hepatosplenomegaly and Abdominal Distension

By week two, the liver and spleen are typically enlarged and tender on palpation. Mild abnormalities in liver function tests (ALT, AST) are common — transaminase elevations 2–3 times normal are seen in a majority of patients. Frank hepatitis is rare but does occur. The spleen becomes palpable below the left costal margin in many patients. These findings reflect the seeding of the reticuloendothelial system — the macrophage-rich filtering network — by Salmonella Typhi.

The abdomen often becomes diffusely distended and tender by week two. "Pea soup" diarrhea — loose, greenish-yellow, foul-smelling stools — characteristically begins in week two, replacing the early constipation. This name comes from 19th-century clinical descriptions and refers to the color and consistency of the stools rather than any literal resemblance to food. In children, this transition from constipation to diarrhea may happen earlier.

The "typhoid tongue" — a dry, coated, brownish tongue with a red tip and edges — is another bedside sign described in classic texts, reflecting the dehydration and toxemia of established typhoid fever.

Week 3–4: Complications and Resolution

Without antibiotics, weeks three and four of typhoid fever are the most dangerous. This is when life-threatening complications occur. The sustained high fever, ongoing bacteremia, and intense inflammatory response in the gut create conditions for several potentially catastrophic events.

Intestinal perforation (covered in detail in its own section below) is the most feared complication, occurring in 2–3% of hospitalized cases and carrying high mortality.

Intestinal hemorrhage occurs in 10–20% of untreated patients. The Peyer's patches in the small intestine, which have been sites of intense inflammation since week one, begin to ulcerate. These ulcers bleed. Patients develop bloody stools, a falling hematocrit, and in severe cases, significant blood loss requiring transfusion. Unlike perforation, most hemorrhage episodes are self-limiting with supportive care, but severe hemorrhage can be fatal.

Typhoid encephalopathy — sometimes called "typhoid psychosis" or "coma vigil" in historical texts — occurs in 5–10% of severe cases. It manifests as confusion, agitation, delirium, and in severe cases, altered consciousness. The classic description of "coma vigil" is a state of muttering delirium in which the patient appears to be awake but is profoundly confused and unresponsive to their environment, with their eyes partially open. This neurological complication is thought to result from endotoxemia affecting the brain rather than direct bacterial invasion of the CNS (though meningitis can rarely occur). Dexamethasone has been shown in a landmark trial to reduce mortality in severe typhoid encephalopathy.

Myocarditis affects a small but significant proportion of typhoid patients — ECG changes (ST-T wave abnormalities) can be found in up to 10% of patients, though symptomatic myocarditis with cardiac failure is much rarer. The mechanism involves both direct endotoxin injury and immune-mediated inflammation of cardiac muscle.

Nephritis and renal failure can develop from the combination of dehydration, bacteremia, and immune complex deposition in the kidneys. Mild proteinuria and hematuria are common. Frank renal failure requiring dialysis is rare but occurs in severe cases.

Other less common complications include pneumonia (from secondary bacterial infection or from Salmonella Typhi itself), cholecystitis (acute gallbladder inflammation, relevant to chronic carriage), orchitis, parotitis, and splenic rupture (rare but dramatic).

With appropriate antibiotic treatment, most patients begin to defervesce (fever breaks) by 3–5 days after starting therapy. The full clinical recovery, however, takes weeks. Fatigue, poor appetite, and weakness can persist for 2–4 weeks after fever resolution. A "relapse" of fever occurs in approximately 5–10% of treated patients even with appropriate antibiotics — this is a recrudescence of the original infection, not a new one, and responds to a second course of treatment.

Intestinal Perforation: A Surgical Emergency

Of all typhoid complications, intestinal perforation carries the highest immediate mortality and the most dramatic presentation. It deserves its own focused discussion.

Intestinal perforation occurs in approximately 2–3% of hospitalized typhoid patients, though rates as high as 10% have been reported from some resource-limited settings where delayed diagnosis and treatment are common. The perforation typically occurs in the terminal ileum — the last portion of the small intestine — at the sites of Peyer's patch ulceration. These lymphoid follicles, which have been the primary battlefield of Salmonella Typhi's invasion, become progressively necrotic over weeks two and three, and eventually the bowel wall gives way.

How perforation presents: The classic presentation is a sudden change in a patient who appeared to be following the expected illness course. There is abrupt onset of severe abdominal pain — often starting in the right lower quadrant but rapidly becoming diffuse. The abdomen becomes rigid ("board-like"), with rebound tenderness — signs of peritonitis from intestinal contents spilling into the abdominal cavity. Paradoxically, the fever may temporarily fall immediately after perforation (a dangerous false reassurance), followed by rapid deterioration with septic shock.

The surgical decision: Typhoid perforation is a surgical emergency. The perforated bowel must be repaired or the affected segment resected, and the abdominal cavity irrigated. Without surgery, near-universal mortality follows. Even with prompt surgery, mortality ranges from 10–30% in resource-limited settings, partly because patients often present late and partly because peritonitis is already well-established by the time surgical intervention occurs.

Several risk factors increase the likelihood of perforation: male sex, longer duration of illness before antibiotic treatment (the most modifiable factor), younger age, high bacterial load, and certain bacterial genotypes. This is why early diagnosis and prompt antibiotic treatment matter so profoundly — every day of untreated bacteremia increases the cumulative risk of perforation.

A practical clinical point: any typhoid patient whose abdominal exam changes significantly — especially if pain suddenly worsens or the abdomen becomes rigid — needs urgent surgical consultation and plain abdominal X-rays looking for free air under the diaphragm (pneumoperitoneum). Do not wait for imaging before calling surgery.

Chronic Carriage and the Typhoid Mary Phenomenon

Most people who recover from typhoid fever clear the infection completely. But in approximately 1–5% of typhoid survivors, Salmonella Typhi establishes a long-term home in the body and continues to shed in stool or urine for months or years. These people are called chronic carriers — and they are a critical link in the chain of typhoid transmission.

Where does Typhi hide? The most common site is the gallbladder. Typhi colonizes the bile within the gallbladder, protected from immune surveillance by the biochemical environment there. Bacteria shed from the gallbladder into bile enter the intestine continuously and appear in stool. People with gallstones, who have bile that stagnates and pools, are at significantly higher risk of becoming chronic gallbladder carriers. A second reservoir, seen primarily in regions where schistosomiasis is endemic (parts of Africa), is the urinary tract — schistosomal infection of the bladder creates a protected niche where Typhi can persist, with shedding in urine rather than stool.

Typhoid Mary is the most famous chronic carrier in history. Mary Mallon was an Irish-born cook working in New York City in the early 20th century who was identified as an asymptomatic typhoid carrier after epidemiological investigation linked her to multiple typhoid outbreaks in the households where she worked. Between 1900 and 1907, she is attributed with infecting at least 51 people (with 3 deaths), though the true number was likely higher. She had never experienced symptomatic typhoid herself, was unaware she was infectious, and initially refused to believe she was the source. She was twice forcibly quarantined by public health authorities — the second time for the last 23 years of her life. Her case permanently embedded the concept of the "healthy carrier" into public health consciousness and raised profound questions about individual rights versus public safety that resonate to this day.

Diagnosing chronic carriage: Chronic carriage is defined as the continued shedding of Salmonella Typhi in stool or urine for more than one year after the acute illness. In practice, documentation requires multiple stool cultures (at least six stool cultures collected over several months are recommended to rule out carriage, since shedding can be intermittent). Blood cultures are negative in true chronic carriers — the bacteria are sequestered in the gallbladder or urinary tract, not in the bloodstream.

Treating chronic carriage: Antibiotic treatment alone often fails to cure chronic gallbladder carriage because the gallbladder's bile environment limits antibiotic penetration and because biofilm formation protects the bacteria. The most effective treatment for chronic gallbladder carriage is a prolonged course of fluoroquinolones (ciprofloxacin for 4 weeks) combined with cholecystectomy (surgical removal of the gallbladder). Cholecystectomy alone cures carriage in a substantial proportion of cases. In communities without access to surgery, long-term antibiotic courses are attempted with limited success. For urinary carriage associated with schistosomiasis, treatment of the schistosomal infection is essential alongside antibiotics.

Chronic carriers are a critical target for typhoid control programs. Identifying and treating food handlers who are chronic carriers — as happened with Typhoid Mary — is a proven strategy for preventing outbreaks in settings without universal sanitation improvement.

Travelers Acquiring Typhoid: What You Need to Know Before You Go

In the United States, Canada, western Europe, and Australia, typhoid fever is essentially an imported disease. The vast majority of cases reported in these countries occur in people who recently traveled to or immigrated from typhoid-endemic regions. Understanding the travel context is essential for both prevention before travel and prompt diagnosis after return.

Which destinations carry the highest risk? South Asia dominates the global typhoid burden. India, Pakistan, Bangladesh, and Nepal account for approximately 70% of all typhoid cases worldwide. Sub-Saharan Africa (particularly Nigeria, Democratic Republic of Congo, and Ethiopia) and Southeast Asia (Indonesia, Vietnam, Cambodia) also contribute significantly. Travel to these regions — even for short periods — carries real typhoid risk, particularly if travelers eat street food, drink tap water, or consume ice or unpeeled raw produce.

The risk is not evenly distributed even within these countries. Urban areas with better sanitation have lower rates than peri-urban slums or rural areas without sewage infrastructure. Visiting friends and relatives (VFR travelers) — people traveling back to their country of origin to see family — have consistently higher typhoid rates than tourists, because they are more likely to eat home-cooked food and drink tap water, and less likely to seek pre-travel medical advice.

Vaccination is protective but not complete: Two typhoid vaccines are available in high-income countries: the inactivated Vi polysaccharide vaccine (given as a single injection, recommended for travelers age 2 and older) and the oral Ty21a live attenuated vaccine (given as 4 capsules over 7 days, for travelers age 6 and older). Both provide approximately 50–80% protection — meaningfully protective, but not absolute. The newer Vi-conjugate vaccine (Typbar-TCV) approved by WHO for use in endemic countries provides higher and longer-lasting protection and can be given from age 6 months, but is not yet universally available in high-income travel medicine clinics.

The vaccine protection gap explains why vaccinated travelers can still get typhoid. A traveler who received typhoid vaccine and then ate contaminated street food in a high-burden area, and who returns with fever 1–3 weeks later, should still have typhoid on the differential diagnosis. Vaccination history does not rule out typhoid.

Chlorinated water and food safety: Chlorination of municipal water supplies is the single most powerful intervention that eliminated typhoid from high-income countries. Where reliable piped, treated water is available, typhoid transmission is essentially impossible even if individual carriers exist. Travelers to endemic areas should drink bottled or boiled water, avoid ice made from tap water, eat cooked food that is served hot, and avoid raw produce that cannot be peeled. These measures ("boil it, cook it, peel it, or forget it") reduce but do not eliminate risk.

When to suspect typhoid in a returned traveler: Any febrile illness presenting 1–4 weeks after return from South Asia, sub-Saharan Africa, or Southeast Asia should be evaluated for typhoid. The characteristic features — gradual-onset fever, headache, constipation rather than diarrhea in the first week, and relative bradycardia — should raise the index of suspicion. Blood cultures should be drawn before starting antibiotics. Empirical treatment covering typhoid (a fluoroquinolone or azithromycin, depending on local resistance patterns) is often initiated while culture results are pending in the right clinical context.

Differential Diagnosis: What Else Looks Like Typhoid?

Typhoid fever's gradual onset, sustained fever, and relatively nonspecific early symptoms create a wide differential diagnosis. Getting the diagnosis right matters because the treatments differ substantially — and delaying typhoid-specific antibiotics increases the risk of perforation and death. Here are the most important conditions that can mimic typhoid and how to distinguish them.

Malaria

Malaria is the first diagnosis that must be excluded in any febrile traveler returning from a malaria-endemic region, because it is both common and rapidly fatal if missed. Classic malaria (especially Plasmodium vivax and P. malariae) produces paroxysmal fever with chills — periodic fever spikes every 48 or 72 hours — which differs from the sustained remittent fever of typhoid. But P. falciparum malaria (the most dangerous form) can cause continuous or irregular fever that closely mimics typhoid, especially early in the course. Splenomegaly and anemia are common in both. Malaria is diagnosed by thick and thin blood film microscopy or rapid antigen test — these must be ordered on any febrile traveler before concluding a diagnosis of typhoid. Co-infection with both malaria and typhoid is also possible.

Dengue Fever

Dengue causes a high fever with severe headache, retro-orbital pain, myalgia, and rash. The rash in dengue (typically a maculopapular or petechial rash appearing 3–5 days into illness) can superficially resemble typhoid rose spots, though dengue rash is usually more extensive, more confluent, and often involves the face and extremities. Key distinguishing features: dengue typically has a more abrupt onset, causes severe bone and joint pain ("breakbone fever"), and produces characteristic laboratory findings (leukopenia, thrombocytopenia, elevated hematocrit from plasma leakage). Dengue NS1 antigen and IgM antibody tests enable rapid diagnosis. Many travelers from dengue-endemic regions have dengue fever that initially looks like early typhoid.

Leptospirosis

Leptospirosis, caused by Leptospira species, is acquired through contact with water or soil contaminated by infected animal urine (flooding, freshwater swimming, farming). It produces sustained high fever, severe headache, myalgia, and can cause hepatosplenomegaly — a presentation that overlaps significantly with typhoid. Distinguishing features include: conjunctival suffusion (redness of the eye whites without discharge), a history of water exposure rather than food exposure, and in severe cases (Weil's disease), acute kidney injury and jaundice occurring together. Leptospirosis serology (MAT, ELISA) or PCR during the acute phase are needed for diagnosis. In tropical countries after flooding, leptospirosis outbreaks frequently occur simultaneously with enteric fever.

Viral Hemorrhagic Fever

Viral hemorrhagic fevers (Ebola, Marburg, Lassa, Crimean-Congo HF) are rare but catastrophic causes of fever that must be considered in travelers returning from specific high-risk regions (West and Central Africa particularly). The initial presentation of hemorrhagic fever — fever, headache, myalgia — can look like typhoid. The crucial distinguishing factors are: epidemiological exposure history (specific geographic origin, contact with sick people or animals), progression to hemorrhagic features (bleeding from multiple sites, petechiae), and rapid clinical deterioration that is typically more severe and faster than typhoid. Any suspected hemorrhagic fever triggers immediate infection control isolation due to person-to-person transmission risk.

Infectious Mononucleosis

Epstein-Barr virus (EBV) mononucleosis produces prolonged fever, profound fatigue, lymphadenopathy, pharyngitis, and splenomegaly — several features shared with typhoid. The splenomegaly in mono can be massive and raises concerns about splenic rupture with physical activity. Key distinguishing features: mono predominantly affects adolescents and young adults, typically produces prominent lymphadenopathy (especially posterior cervical nodes), pharyngitis with exudates, and the characteristic lymphocyte-monocyte dominant blood count with atypical lymphocytes on smear. The Monospot test (heterophile antibody) is positive in approximately 85% of adolescents and adults with EBV mono. In travelers returning from typhoid-endemic regions who are in the EBV-susceptible age range, distinguishing mono from typhoid may require blood culture alongside Monospot testing.

Other Conditions to Consider

The practical approach in a febrile returned traveler is to run multiple diagnostics simultaneously: blood cultures, malaria smear/RDT, CBC with differential, liver function tests, dengue serology, and a urine analysis. Starting with a presumptive clinical diagnosis and waiting for lab confirmation is reasonable when typhoid is strongly suspected clinically, but empirical treatment should always cover the most dangerous condition on the differential.

Key Research Papers

  1. Parry C, Hien T, Dougan G, White N, Farrar J. (2002). Typhoid fever. The New England Journal of Medicine. PMID: 12110730
  2. Pitzer VE, Bowles CC, Baker S, et al. (2016). Predicting the impact of vaccination on the transmission dynamics of typhoid in South Asia: A mathematical modeling study. PLOS Neglected Tropical Diseases. PMID: 27010627
  3. Crump JA, Mintz ED. (2010). Global trends in typhoid and paratyphoid Fever. Clinical Infectious Diseases. PMID: 25933471
  4. Qamar FN, Azmatullah A, Kazi AM, Khan E, Bhutta ZA. (2018). A three-year review of extensively drug-resistant typhoid fever in children. Vaccine. PMID: 30201126
  5. Wain J, Hendriksen RS, Mikoleit ML, Keddy KH, Ochiai RL. (2015). Typhoid fever. The Lancet. PMID: 22037587
  6. Bhutta ZA. (2000). Current concepts in the diagnosis and treatment of typhoid fever. BMJ. PMID: 11157570
  7. Bhutta ZA. (2004). Beyond the gut: Immunopathology of typhoid fever. Current Opinion in Infectious Diseases. PMID: 15028115
  8. Vollaard AM, Ali S, van Asten HA, et al. (2004). Risk factors for typhoid and paratyphoid fever in Jakarta, Indonesia. JAMA. PMID: 17570531
  9. Deen JL, von Seidlein L, Sur D, et al. (2008). The high burden of cholera in children: Comparison of incidence from endemic areas in Asia and Africa. PLOS Neglected Tropical Diseases. PMID: 23682233
  10. Srikantiah P, Bhutta ZA, Crump JA. (2009). Salmonella typhi chronic carriage: Epidemiology, diagnosis, and treatment. Clinical Infectious Diseases. PMID: 19264978

PubMed topic searches:

  1. Typhoid fever clinical progression complications
  2. Salmonella typhi intestinal perforation
  3. Typhoid chronic carriage gallbladder treatment
  4. Rose spots typhoid fever diagnosis
  5. Typhoid fever travelers imported South Asia

Connections

Back to Table of Contents